Cargando…
Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer
Oxaliplatin is widely used in the frontline treatment of colorectal cancer (CRC), but an estimated 50% of patients will eventually stop responding to treatment due to acquired resistance. This study revealed that diminished MEIS1 expression was detected in CRC and harmed the survival of CRC patients...
Autores principales: | Li, Yimin, Gan, Yaqi, Liu, Jiaxin, Li, Juanni, Zhou, Zhengwei, Tian, Ruotong, Sun, Ruizheng, Liu, Jiaqi, Xiao, Qing, Li, Yuanyuan, Lu, Pengyan, Peng, Yulong, Peng, Yuqian, Shu, Guang, Yin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964798/ https://www.ncbi.nlm.nih.gov/pubmed/35351858 http://dx.doi.org/10.1038/s41392-022-00902-6 |
Ejemplares similares
-
Mutation of Elfn1 in Mice Causes Seizures and Hyperactivity
por: Dolan, Jackie, et al.
Publicado: (2013) -
Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer
por: Ma, Gang, et al.
Publicado: (2021) -
lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression: ELFN1-AS1 promotes gastric cancer progression
por: Huang, Jinxi, et al.
Publicado: (2023) -
lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB
por: Peng, Shuangqin, et al.
Publicado: (2022) -
lncRNA
ELFN1-AS1 promotes proliferation, migration and invasion and suppresses apoptosis in colorectal cancer cells by enhancing
G6PD activity
: lncRNA
ELFN1-AS1 promotes the progression of colorectal cancer
por: Wu, Fahong, et al.
Publicado: (2023)